Iventis, a leading provider of visual planning solutions, has announced the launch of its revolutionary Iventis Version 2.0 platform. The successful funding round allowed the company to expand its team and enhance its platform to meet the needs of venues, event suppliers, organisers, and consultants around the world.
The Iventis visual planning platform has been utilised by prominent international events such as the 2023 Special Olympics World Games in Berlin, Dubai Expo 2020, Commonwealth Games 2022, European World Championships, and the World Cup. The new platform is designed to support events of any size and enables users to rapidly create detailed event site and operational plans.
Joe Cusdin, CEO of Iventis, commented: “We are thrilled to introduce Iventis Version 2.0, which marks a significant advancement in visual event planning technology. Our platform has earned the trust of some of the world’s most prestigious events, and we’ve carefully incorporated their valuable feedback. With this development, we remain committed to empowering even more event professionals with even greater capabilities to plan and deliver events of any size and complexity effortlessly.”
Highlights of the platform include the ability to plan every aspect of events including infrastructure, transport and logistics, workforce, safety and crowd management, alongside the ability to work together on plans in real-time with internal teams and external stakeholders. It also offers a Digital Twin product, allowing venues to integrate their CAD drawings and explore a virtual 3D version of their space.
The enhancements to Iventis Version 2.0 promise substantial efficiency gains throughout the event planning and delivery process, regardless of event size or complexity.
Iventis, founded by major events industry veteran Joe Cusdin, is backed by Mercia Ventures and has been trusted in the event planning industry since 2015.
The post Iventis Unveils Upgraded Visual Planning Platform to Maximize Event Planning Productivity first appeared on BusinessMole.